Perkins Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-233	Closed	-$4K	–	119
2019 Q3	$4K	Sell	233 -19,659	-99%	-$383K	﹤0.01%	112
2019 Q2	$487K	Sell	19,892 -1,018	-5%	-$31.8K	0.34%	81
2019 Q1	$753K	Buy	20,910 +18,122	+650%	+$745K	0.5%	63
2018 Q4	$101K	Sell	2,788 -5,794	-68%	-$488K	0.08%	115
2018 Q3	$1.34M	Buy	8,582 +1,885	+28%	+$279K	0.8%	42
2018 Q2	$894K	Buy	6,697 +273	+4%	+$41.3K	0.64%	53
2018 Q1	$1.59M	Sell	6,424 -174	-3%	-$49K	1.43%	14
2017 Q4	$1.83M	Buy	6,598 +1,220	+23%	+$465K	1.76%	10
2017 Q3	$2.18M	Sell	5,378 -144	-3%	-$75.1K	2.28%	7
2017 Q2	$3.27M	Sell	5,522 -57	-1%	-$33.3K	3.63%	5
2017 Q1	$3.43M	Sell	5,579 -178	-3%	-$63.3K	3.54%	5
2016 Q4	$1.17M	Sell	5,757 -7	-0.1%	-$1.59K	1.28%	22
2016 Q3	$1.51M	Buy	5,764 +1,889	+49%	+$579K	1.51%	17
2016 Q2	$1.16M	Buy	3,875 +2,642	+214%	+$929K	1.33%	23
2016 Q1	$525K	Hold	1,233	–	–	0.66%	54
2015 Q4	$610K	Buy	+1,233	New	+$891K	0.65%	53
2014 Q2	–	Sell	-514	Closed	-$1.16M	–	146
2014 Q1	$1.16M	Sell	514 -31	-6%	-$79.4K	0.82%	46
2013 Q4	$1.13M	Buy	+545	New	+$1.18M	0.76%	48